港股異動 | 耐世特(1316.HK)續跌逾4% 中期純利同比下降99%
格隆匯8月20日丨耐世特(1316.HK)今日續跌,暫三日連跌累跌約11%,現報4.97港元,跌4.61%,暫成交2882萬港元,最新總市值124億港元。耐世特本週二(18日)晚間公佈中期業績稱,期內公司權益持有人應占利潤130.1萬美元,同比下降99.01%;基本及攤薄每股盈利0.001美元。期內毛利率為10.1%,而2019年同期則為15.6%。績後美銀證券發研報指,耐世特上半年毛利率跌至10.1%,差過預期,但該行上調公司2020年盈利預測,認為經營方面將有上行空間,目標價升至5.8港元,重申“中性”評級,相信股價已反映了下半年銷售反彈的情況。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.